What's breaking now, across thousands of outlets.
'I can't go through World FTD Awareness Week without talking about Bruce. He is the driving force behind my advocacy,' Emma Heming Willis wrote.
We haven't written up this one. Global News has the full story — the link below goes straight to it.
Plus news about Regeneron. Summit Therapeutics to test cancer drug with Datroway: The biotech agreed to partner with AstraZeneca and Daiichi Sankyo on a clinical trial collaboration, testing its…
Settling for “good enough” undermines clinical trial quality in drug development and risks trial failure and regulatory rejection. Here’s what pursuing greatness actually requires.
The Treasury Department has started mailing one-time $500 payments to HealthCare.gov customers in 30 states who paid full price for 2026 coverage.
The next era of primary care will require intelligence that moves directly into the workflow, writes Sentara Health's head of ambulatory care.
Only a small fraction of young people with opioid use disorder receive addiction medications, and few stay on them for long, a study finds.
Stats SA says cardiovascular diseases accounted for 17.8% of registered deaths in South Africa in 2024, with hypertension and stroke among the leading causes.
